TickerFacts.

Anavex Life Sciences Corp. (AVXL): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Stock splits: 1-for-4, first reflected in a filing dated 2015-12-29. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

85.29M
Year ended 2025-09-30
+3.5%
3-year compound annual growth
2010-09-30: 21.44M2011-09-30: 25.17M2012-09-30: 28.17M2013-09-30: 31.91M2014-09-30: 9.80M2015-09-30: 18.58M2016-09-30: 35.15M2021-09-30: 69.80M2022-09-30: 76.91M2023-09-30: 79.79M2024-09-30: 83.47M2025-09-30: 85.29M85.29M
2010-09-30 Weighted Average Diluted Shares (shares) 2025-09-30

Paler bars were last filed before a stock split, on the old share basis.

Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-09-3085.29M+2.2%2026-08-28, From 2024-10-01
2024-09-3083.47M+4.6%2026-08-28, From 2023-10-01
2023-09-3079.79M+3.7%2026-08-28, From 2022-10-01
2022-09-3076.91M+10.2%2023-11-27, From 2021-10-01
2021-09-3069.80Mn/c2023-11-27, From 2020-10-01
No annual figure between 2016-09-30 and 2021-09-30.
2016-09-3035.15M+89.2%2016-12-14, From 2015-10-01
2015-09-3018.58M+89.6%2016-12-14, From 2014-10-01
2014-09-309.80Mn/c2016-12-14, From 2013-10-01
2013-09-3031.91M+13.3%2014-12-29, From 2012-10-01
2012-09-3028.17M+11.9%2013-12-30, From 2011-10-01
2011-09-3025.17M+17.4%2012-12-31, From 2010-10-01
2010-09-3021.44Mn/a2011-12-22, From 2009-10-01